Inhibition of cell growth of human hepatoma cell line (Hep G2) by a farnesyl protein transferase inhibitor: A preferential suppression of ras farnesylation

International Journal of Cancer

Volumn 65, Issue 5, 1996, Pages 620-626

  Nagase, Toshihiko ^a   Kawata, Sumio ^a   Tamura, Shinji ^a   Matsuda, Yukihiko ^a   Inui, Yoshiaki ^a   Yamasaki, Eiji ^a   Ishiguro, Hiroshi ^a   Ito, Toshio ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MANUMYCIN; SQUALENE SYNTHASE;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME INHIBITION; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; ONCOGENE RAS; PRIORITY JOURNAL;

ALKYL AND ARYL TRANSFERASES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CHOLESTEROL; GTP-BINDING PROTEINS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; POLYENES; POLYUNSATURATED ALKAMIDES; RAP GTP-BINDING PROTEINS; TRANSFERASES; TUMOR CELLS, CULTURED;

EID: 0029940817     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960301)65:5<620::AID-IJC11>3.0.CO;2-B     Document Type: Article

References (37)

1. BARBACID, M., ras genes. Ann. Rev. Biochem., 56, 779-827 (1987).
2. BROWN, M.S., GOLDSTEIN, J.L., PARIS, K.J., BURNIER, J.P. and MARSTERS, J.C., JR., Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation. Proc. nat. Acad. Sci. (Wash.), 89, 8313-8316 (1992).
3. BUSS, J.E., QUILLIAM, L.A., KATO, K., CASEY, P.J., SOLSKI, P.A., WONG, G., CLARK, R., MCCORNICK, F., BOKOCH, G.M. and DER, C.J., The COOH-terminal domain of the RaplA (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein. Mol. Cell Biol., 11, 1523-1530 (1991).
4. CAMPA, M.J., CHANG, K.-J., VEDIA, L.M., REEP, B.R. and LAPETINA, E.G., Inhibition of ras-induced germinal vesicle breakdown in Xenopus oocytes by rap-1B. Biochem. biophys. Res. Comm., 174, 1-5 (1991).
5. CREWS, C.M. and ERIKSON, R.L., Extracellular signals and reversible protein phosphorylation: What to mek of it all. Cell, 74, 215-217 (1993).
6. CROWELL, P.L., CHANG, R.R., REN, Z., ELSON, C.E. and GOULD, M.N., Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J. biol. Chem., 266, 17679-17685 (1991).
7. FARNSWORTH, C.C., GELB, M.H. and GLOMSET, J.A., Identification of geranylgeranyl-modified proteins in Hela cells. Science (Wash.), 247, 320-322 (1990).
8. GIBBS, J.B., Ras C-terminal processing enzymes - new drus targets? Cell, 65, 1-4 (1991).
9. GIBBS, J.B., POMPLIANO, D.L., MOSSER, S.D., RANDS, E., LINGHAM, R.B., SINGH, S.B., SCOLNICK, E.M., KOHL, N.E. and OLIFF, A., Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J. biol. Chem , 268, 7617-7620 (1993).
10. GIBBS, J.B., SCHABER, M.D., SCHOFIELD, T.L., SCOLNICK, E.M. and SIGAL, I.S. Xenopus oocyte germinal-vesicle breakdown induced by [Val 12]ras is inhibited by a cytosol-localized ras mutant. Proc. nat. Acad. Sci. (Wash.), 86, 6630-6634 (1989).
11. GIBBS, J.B., SIGAL, I.S. and SCOLNICK, E.M., Biochemical properties of normal and oncogenic ras p 21. TIBS, 10, 350-353 (1985).
12. GOLDSTEIN, J.L., BROWN, M.S., STRDLEY, S.J. REISS, Y. and GIERASH, L.M., Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase. J. biol. Chem., 266, 15575-15578 (1991).
13. HANCOCK, J.F., MAGEE, A.I., CHILDS, J.E. and MARSHALL, C.J., All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57, 1167-1177 (1989).
14. HARA, M., AKASAKA, K., AKINAGA, S., OKABE, M., NAKANO, H., GOMEZ, R., WOOD, D., UH, M. and TAMANOI, F., Identification of ras farnesyltransferase inhibitors by microbial screening. Proc. nat. Acad. Sci. (Wash.), 90, 2281-2285 (1993).
15. JACKSON, J.H., COCHRANE, C.G., BOURNE, J.R., SOLSKI, P.A., BUSS, J.E. and DER, C.J., Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc. nat. Acad. Sci (Wash.), 87, 3042-3046 (1990).
16. JAMES, G.L., BROWN, M.S., COBB, M.H. and GOLDSTEIN, J.L., Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells. J. biol. Chem., 269, 27705-27714 (1994).
17. JAMES, G.L , GOLDSTEIN, J.L., BROWN, M.S., RAWSON, T.E., SOMERS, T.C., MCDOWELL, R.S., CROWLEY, C W., LUCAS, B.K., LEVINSON, A.D. and MARSTERS, J.M., JR., Benzodiazepine peptidomimetics: potent inhibitors of ras farnesylation in animal cells. Science (Wash.), 260, 1937-1942 (1993).
18. KAWATA, M., FARNSWORTH, C.C., YOSHIDA, Y., GELB, M.H., GLOMSET, J.A. and TAKAI, Y., Post-translationally processed structure of the human platelet protein smg p21B: evidence for geranylgeranylation and carboxyl methylation of the C-terminal cysteine. Proc. nat. Acad. Sci. (Wash.), 87, 8960-8964 (1990a).
19. KAWATA, S., TAKAISHI, K., NAGASE, T., ITO, N., MATSUDA, Y., TAMURA, S., MATSUZAWA, Y and TARUI, S., Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis. Cancer Res., 50, 3270-3273 (1990b).
20. KITAYAMA, H., SUGIMOTO, Y., MATSUZAKI, Y., IKAWA, Y. and NODA, M., A ras-related gene with transformation suppressor activity. Cell. 56, 77-84 (1989).
21. KOHL, N.E., MOSSER, S.D., DESOLMS, S.J., GILLIANI, E.A., POMPLIANO, D.L., GRAHAM, S.L. and SMITH, R.L., Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (Wash.), 260, 1934-1937 (1993).
22. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
23. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with the Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
24. MALTESE, W.A., Post-translational modification of proteins by isoprenoids in mammalian cells. FASEB J., 4, 3319-3328 (1990).
25. MALTESE, W.A., DEFENDINI, R., GREEN, R.A., SHERIDAN, K.M. and DONLEY, D.K., Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. clin. Invest., 76, 1748-1754 (1985).
26. MAZIERE, C., MAZIERE, J.C., MORA, L. and POLONOVSKI, J., Rapid analysis of cellular lipids without extraction. J. biochem. biophys. Meth., 14, 267-272 (1987).
27. ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell, 62, 81-88 (1990).
28. RICHARDS, C.A., SHORT, S.A., THORGEIRSSON, S.S. and HUBER, B.E., Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis. Cancer Res., 50, 1521-1527 (1990).
29. RILLING, H.C., BREUNGER, E., EPSTEIN, W.W. and CRAIN, P.F., Prenylated proteins: the structure of the isoprenoid group. Science (Wash.), 247, 318-320 (1990).
30. SCHAFER, W.R., KIM, R., STERNE, R., THORNER, J., KIM, S.H. and RINE, J., Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science, 245, 379-385 (1989).
31. SHAPIRO, D.J., NORDSTROM, J.L., MITSCHELEN, J.J., ROSWELL, V.W. and SCHIMKE, R.T., Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim. biophys. Acta. 370, 369-377 (1974).
32. SHIRASAWA, S., FURUSE, M., YOKOYAMA, N. and SASAZUKI, T., Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (Wash.), 260, 85-88 (1993).
33. STACEY, D.W., FEIG, L.A. and GIBBS, J.B., Dominant inhibitory ras mutants selectively inhibit the activity of either cellular or oncogenic ras. Mol. Cell Biol., 11, 4053-4064 (1991).
34. TAKADA, S. and KOIKE, K., Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells. Oncogene, 4, 189-193 (1989).
35. TAKAI, Y., KAIBUCHI, K., KIKUCHI, A. and KAWATA, M., Small GTP-binding proteins. Int. Rev. Cytol., 133, 187-230 (1992).
36. ZHANG, X.K., HUANG, D.P., CHIU, D.K. and CHIU, J.F., The expression of oncogenes in human developing liver and hepatomas. Biochem. biophys. Res. Comm., 142, 932-938 (1987).
37. ZHANG, X.K., HUANG, D.P., QIU, D.K. and CHIU, J.F., The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene, 5, 909-914 (1990).